Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Oral Lichen Planus~* Oral Erosive Area More Than 1cm²~* Lichen Planus Pathologically Proven~Exclusion Criteria:~* No Previous Treatment by Rapamycin~* Non Child Bearing Or Breast Feeding Woman~* Patient Who Cannot Be Treated By Rapamycin Or Betamethasone~* Chronic Renal Insufficiency (Creatinin Clearance \< 40ml/Mn)~* Ongoing Treatment By Topical Calcineurin Inhibitors Or Systemic Steroids Or Retinoids Or Systemic Immunosuppressors Or Thalidomide Or Griseofulvin Or Antimalarials~* Cholesterolemia \>7.8 Mmol/L Or Hypertriglyceridemia \>3.95mmol/L Non Responsive To Medical Treatments~* Leucopenia (\<3000/Mm3)~* Thrombopenia (\<100 000/Mm3)~* Hypertransaminasemia (\>3n)~* Hypersensitivity To Macrolides

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- T (Type: EXPERIMENTAL): TOPICAL SIROLIMUS AND PETROLATUM IN ORABASE
- C (Type: ACTIVE_COMPARATOR): TOPICAL BETAMETHASONE 0.05% in ORABASE AND PHOSAL

Based on this trial design, predict the completion outcome and termination type (if applicable).